Mupirocin
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days, depending on response Notes: Clip hair and clean area before application. Avoid contact with eyes. Use with Elizabethan collar if licking is a concern. |
| Cat | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Cats may groom; use caution and consider protective collar. |
| Horse | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Clean area before application. May require bandaging. |
| Cattle | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Not commonly used; consider other approved topical antibiotics. |
| Small Ruminants | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Not commonly used; consider other approved topical antibiotics. |
| Rabbit | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Prevent ingestion; use Elizabethan collar if needed. |
| Bird/Poultry | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Not commonly used; ensure feathers are dry before application. |
| Exotic/Other | Topical | Apply thin layer to affected area | 2-3 times daily | Duration: 5-14 days Notes: Use with caution in small mammals; prevent ingestion. |
Clinical Indications & Species Uses
- Topical treatment of bacterial skin infections caused by susceptible Gram-positive organisms, especially staphylococci and streptococci
- Treatment of pyoderma (superficial and deep) caused by Staphylococcus pseudintermedius
- Treatment of impetigo
- Treatment of infected wounds and abrasions
- Treatment of interdigital furunculosis (as adjunctive therapy)
- Treatment of pyoderma (especially superficial)
- Treatment of infected wounds and abscesses (topical adjunct)
- Treatment of feline acne (secondary infection)
- Treatment of superficial skin infections (e.g., bacterial dermatitis, infected wounds)
- Treatment of skin infections (e.g., bacterial dermatitis, abscesses) as topical adjunct
- Treatment of skin infections in small mammals (e.g., guinea pigs, rats) and reptiles (e.g., scale rot) as topical adjunct
Pharmacology & Mechanism of Action
Drug Class: Antibacterial | Pharmacological Group: Monoxycarbolic acid derivative
Mechanism of Action: Mupirocin inhibits bacterial protein synthesis by reversibly binding to bacterial isoleucyl-tRNA synthetase, preventing the incorporation of isoleucine into protein chains. This action is bacteriostatic at low concentrations and bactericidal at high concentrations. It is highly active against staphylococci and streptococci, including methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus pseudintermedius (MRSP).
Pharmacodynamics: Mupirocin exhibits time-dependent killing and has a post-antibiotic effect. Its activity is pH-dependent, with optimal activity at acidic pH. It is primarily effective against Gram-positive organisms, with limited activity against Gram-negative bacteria and anaerobes. Resistance can develop via mutation of the target enzyme or acquisition of plasmid-mediated mupA gene.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Known hypersensitivity to mupirocin or any component of the formulation
- Use in eyes (ophthalmic formulations are not available; use only ophthalmic-specific products)
- Use on large areas of broken skin or in patients with renal impairment (due to potential absorption of polyethylene glycol vehicle)
- For topical use only; avoid contact with eyes, nose, and mouth.
- Do not use in large quantities on open wounds or burns, especially in patients with renal dysfunction, due to potential absorption of the vehicle (polyethylene glycol).
- Prolonged use may result in overgrowth of non-susceptible organisms, including fungi.
- Use with caution in animals with a history of allergic reactions to antibiotics.
- In food animals, observe withdrawal times and follow label directions.
- Keep out of reach of children and animals.
Adverse Effects & Reactions
Common:
- Local irritation
- Redness
- Stinging or burning sensation at application site
Serious / Severe:
- Allergic contact dermatitis
- Systemic absorption leading to renal toxicity (rare, with large area application)
Rare:
- Superinfection with resistant organisms
- Anaphylaxis (extremely rare)
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Chloramphenicol | May antagonize the antibacterial effect of mupirocin; avoid concurrent use. | Moderate |
| Other topical antibiotics (e.g., neomycin, bacitracin) | No significant interactions; may be used in combination if needed. | Mild |
| Systemic aminoglycosides | No significant interaction; but monitor renal function if large areas are treated. | Mild |
Overdose & Toxicity Management
Signs of Toxicity:
- Local irritation
- Excessive licking or grooming
- Gastrointestinal upset if ingested (e.g., vomiting, diarrhea)
Emergency Treatment Protocol: If ingested, provide supportive care. Induce vomiting only if large amounts were ingested and within a short time. Administer activated charcoal to reduce absorption. Monitor for signs of systemic toxicity. For topical overdose, wash off with soap and water. No specific antidote.
Food Animal Withdrawal Times
Mupirocin is not approved for food animals; however, due to minimal systemic absorption, withdrawal times are generally not required. Check local regulations. For extra-label use in food animals, consult a veterinarian and follow appropriate withdrawal periods.
Storage, Handling & Regulatory Information
Storage Temperature: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F).
Handling & Special Conditions: Keep tightly closed. Do not freeze. Keep away from excessive heat.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Not FDA-approved for veterinary use; approved for human use as topical antibiotic.
Extra-Label (Off-Label) Use: In the US, mupirocin is not FDA-approved for veterinary use, but it can be used extra-label under AMDUCA (Animal Medicinal Drug Use Clarification Act) by or on the order of a veterinarian. For food animals, a valid veterinarian-client-patient relationship is required, and withdrawal times must be established.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)